Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brilacidin for Oral Mucositis in Head and Neck Cancer
NCT02324335Phase 2Completed
- Sponsor
- Innovation Pharmaceuticals Inc.
- Start
- Aug 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of brilacidin in oral mucositis (OM), sponsored by Innovation Pharmaceuticals Inc.. Started Aug 2014; status: completed.
02
Drugs
brilacidin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02324335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324335.